11. Genomics and Cancer Risk Assessment

  1. Prof. Dr. Günter Obe3,4,
  2. Dr. Burkhard Jandrig5,
  3. Prof. Dr. Gary E. Marchant6,
  4. Dipl. Päd. Holger Schütz7 and
  5. Prof. Dr. Peter M. Wiedemann8
  1. Michal R. Schweiger1 and
  2. Bernd Timmermann2

Published Online: 27 APR 2011

DOI: 10.1002/9783527634613.ch11

Cancer Risk Evaluation: Methods and Trends

Cancer Risk Evaluation: Methods and Trends

How to Cite

Schweiger, M. R. and Timmermann, B. (2011) Genomics and Cancer Risk Assessment, in Cancer Risk Evaluation: Methods and Trends (eds G. Obe, B. Jandrig, G. E. Marchant, H. Schütz and P. M. Wiedemann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527634613.ch11

Editor Information

  1. 3

    Ret. from University Duisburg-Essen, Germany

  2. 4

    Gershwinstrasse 33, 14513 Teltow, Germany

  3. 5

    Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany

  4. 6

    Arizona State University, Sandra Day O'Connor College of Law, P.O. Box 877906, Tempe, AZ 85287-796, USA

  5. 7

    Research Center Jülich, Institute of Neuroscience and Medicine (INM-8), 52425 Jülich, Germany

  6. 8

    Karlsruher Institut für Technologie (KIT), TAB – Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag, Neue Schönhauser Straße 10, 10178 Berlin, Germany

Author Information

  1. 1

    Max-Planck Institute for Molecular Genetics, Department of Vertebrate Genomics, Ihnestrasse 63–73, 14195 Berlin, Germany

  2. 2

    Max-Planck Institute for Molecular Genetics, Ihnestrasse 63–73, 14195 Berlin, Germany

Publication History

  1. Published Online: 27 APR 2011
  2. Published Print: 20 APR 2011

ISBN Information

Print ISBN: 9783527327539

Online ISBN: 9783527634613

SEARCH

Keywords:

  • bioinformatics;
  • bisulfite conversion;
  • gene expression;
  • methylation patterns;
  • monogenetic diseases;
  • next-generation sequencing;
  • SNP

Summary

This chapter contains sections titled:

  • Introduction

  • Tissue Material

  • Analysis Technologies

  • Outlook for Individualized Cancer Treatment

  • References